关于口腔粘膜粘合剂的研究进展
1State Key Laboratory of Oral Diseases & National Clinical Research Center for Oral Diseases & Dept. of Preclinical Stomatology, West China School of Stomatology, Sichuan University, Chengdu 610041, China.
概括
口服药物输送面临着由于口腔环境的挑战. 本综述探讨了口腔粘膜粘合材料的进展,以持续释放药物和增强生物可用性.
科学领域:
- 生物医学工程 生物医学工程
- 药品制造 药品制造 药品制造
- 材料科学 材料科学 材料科学
背景情况:
- 口服粘膜管理为治疗全身和口腔疾病提供了方便的途径.
- 口腔环境为药物输送带来了独特的挑战,包括水分,运动和开放性.
- 目前正在开发局部粘合剂,以克服这些挑战,以实现持续的药物输送.
研究的目的:
- 审查口腔粘膜粘合材料的研究进展情况.
- 突出这些材料在改善口服药物输送方面的潜力.
- 讨论克服药物管理口腔微环境局限性的进展.
主要方法:
- 关于口腔粘膜粘合材料的最新研究的文献综述.
- 分析影响药物输送的口腔独特特性.
- 检查持续释放的粘合剂的开发和应用.
主要成果:
- 口服粘膜粘合剂在持续的药物输送方面显示出显著的前景.
- 这些药物可以通过克服口腔微环境的挑战来提高药物的生物可用性.
- 最近的研究重点是开发用于有效口服粘膜药物管理的创新材料.
结论:
- 口腔粘膜粘合材料是先进药物输送的有希望的战略.
- 在这个领域进行进一步的研究和开发可以带来更好的治疗结果.
- 粘合剂对于释放口服粘膜药物管理的全部潜力至关重要.
相关概念视频
01:24Drugs for Peptic Ulcer Disease: Sucralfate as Mucosal Protective Agents
472
In the intricate landscape of the gastric lumen, excessive acid secretion disrupts the natural defense mechanisms, weakening the mucus-bicarbonate barrier. This vulnerability allows pepsin to infiltrate epithelial cells, digesting mucosal proteins and triggering erosion, leading to ulcer formation.
In this scenario, mucosal protective agents like sucralfate play an essential role. Sucralfate, a complex of sulfated sucrose and aluminum hydroxide, demonstrates its usefulness in acidic conditions,...
In this scenario, mucosal protective agents like sucralfate play an essential role. Sucralfate, a complex of sulfated sucrose and aluminum hydroxide, demonstrates its usefulness in acidic conditions,...
472
01:20Drugs for Peptic Ulcer Disease: Prostaglandin Analogs as Mucosal Protective Agents
423
The gastric mucosa produces prostaglandins E2 (PGE2) and prostacyclin (PGI2), crucial in maintaining gastric health. They exert cytoprotective effects, including increasing bicarbonate secretion, releasing protective mucin, reducing gastric acid output, and preventing harmful vasoconstriction. These effects are mediated through various receptors, such as EP1, EP2, EP3, and EP4.
Non-steroidal anti-inflammatory drugs (NSAIDs) can induce peptic ulcers by inhibiting cyclooxygenase, decreasing...
Non-steroidal anti-inflammatory drugs (NSAIDs) can induce peptic ulcers by inhibiting cyclooxygenase, decreasing...
423